Ogwang C., Kimani D., Edwards NJ., Roberts R., Mwacharo J., Bowyer G., Bliss C., Hodgson SH., Njuguna P., Viebig NK., Nicosia A., Gitau E., Douglas S., Illingworth J., Marsh K., Lawrie A., Imoukhuede EB., Ewer K., Urban BC., S. Hill AV., Bejon P., Leroy O., Cisse B., Sirima S., Bojang K., Murphy G., Karanja H., Nyamako L., De Cassan S., Awuondo K., Kwiatkowski D., Rockett K., Gilbert S., Anagnostou N., Soipei P., Peshu J., Petersen I., Mutinda B., Waithira N., Bashraheil M., Shangala J., Moyle S., Berrie E., Targett G., Thera M., Milligan P., Ogutu B., Etyang A.

Vaccination with the recombinant viral vectors chimpanzee adenovirus 63 followed by modified vaccinia Ankara both encoding the malaria sequence ME-TRAP conferred 67% protection against infection with Plasmodium falciparum in Kenyan adults.

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults

DOI

Type

Journal

Publisher

Publication Date

Volume